Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Tenofovir alafenamide
(TAF) for prevention of mother-to-child transmission of hepatitis B virus among pregnant
women with high level HBV DNA.